Loading…

Humacyte announced a $3.4 million U.S. Department of Defense contract to support additional clinical sites for its Phase II vascular trauma trial in the U.S.
“Humacyte today announced a $3.4 million D0D contract to help support additional clinical sites for Humacyte’s Phase II vascular trauma trial.”massdevice.com
Summarized from public sources; check the original articles before acting on it.